Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Biogen Inc.
About BIIB
Biogen Inc. is a global biopharmaceutical company. The Company is focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It operates a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS, and FUMADERM for the treatment of severe plaque psoriasis. It also collaborations with Eisai on the commercialization of LEQEMBI for the treatment of Alzheimer's disease and Sage on the commercialization of ZURZUVAE for the treatment of Postpartum Depression (PPD).
Find out what a historical investment in Biogen Inc. would be worth today using our BIIB stock calculator.
Market Capitalisation
$29.43B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.27M
High today
$205.97
Low today
$198.86
Open price
$199.33
52-week high
$202.41
52-week low
$119.18
Ready to start your investing journey with Stake?
Open an accountHow do I buy BIIB shares in Australia?
Buying BIIB shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Biogen Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in BIIB
What is the ticker symbol of Biogen Inc.?
The ticker symbol for Biogen Inc. is BIIB.
How much is one share of BIIB?
One share of BIIB is valued at $205.38 as of 13 May 2026.
What is the market capitalisation of Biogen Inc. BIIB?
As of 13 May 2026 Biogen Inc. has a market cap of $29.43B.
What is the P/E ratio of BIIB?
The Price to Earnings ratio of BIIB is 21.39.
What is the Earnings Per Share of BIIB?
The Earnings Per Share of BIIB is $9.32.
What is the 52-week high for Biogen Inc. stock?
The Biogen Inc. 52-week high stock price is $202.41.
What is the 52-week low for Biogen Inc. stock?
The Biogen Inc. 52-week low stock price is $119.18.
Can I buy BIIB shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BIIB shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BIIB on Stake
- Buy BIIB from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of BIIB from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
BIIB related stocks